RETNLB anticorps

N° du produit ABIN2422115

Détail du produit anti-RETNLB anticorps

Antigène: RETNLB (Resistin Like beta (RETNLB))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RETNLB est non-conjugé

Application: ELISA, Immunohistochemistry (IHC)

Purification: Affinity purification

Immunogène: Recombinant protein of human RETNLB

Isotype: IgG

Information d'application

Indications d'application: IHC 1:50-1:200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.3 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Agent conservateur: Sodium azide

Conseil sur la manipulation: Avoid freeze / thaw cycles.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze / thaw cycles.

Détails sur RETNLB

Antigène: RETNLB (Resistin Like beta (RETNLB))

Autre désignation: RETNLB (RETNLB Produits)

Synonymes: anticorps FIZZ1, anticorps FIZZ2, anticorps HXCP2, anticorps RELM-beta, anticorps RELMb, anticorps RELMbeta, anticorps XCP2, anticorps RETNLB, anticorps 9030012B21Rik, anticorps Fizz2, anticorps Relmb, anticorps Xcp3, anticorps resistin like beta, anticorps RETNLB, anticorps Retnlb

Sujet: Resistin-like betais aproteinthat in humans is encoded by theRETNLBgene. An infusion of either resistin or RELMB in rats rapidly induced severe hepatic but not peripheral insulin resistance. Increases in circulating resistin or RELMB levels markedly stimulated hepatic glucose production despite the presence of fixed physiologic insulin levels. This enhanced rate of glucose output was due to increased flux through glucose-6-phosphatase. The results supported the notion that a novel family of fat- and gut-derived circulating proteins modulates hepatic insulin action.

Pathways: Hormone Activity